Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Oneview HealthcareASX:ONE 37 Revenue per Share is A$0.03 as of Jun. 2026. GuruFocus rates ASX:ONE with a GF Score™ of 37/100 and a GF Value™ of A$0.39 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 612 Healthcare Providers & Services companies, Oneview Healthcare ranks worse than 67.16% on this metric.
Oneview Healthcare's revenue per share for the
six
months ended in Jun. 2026 was A$0.02.
Oneview Healthcare's revenue per share for the trailing twelve months (TTM) ended in Jun. 2026 was A$0.03.
Warning Sign:
Oneview Healthcare PLC revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue Per Share Growth Rate of Oneview Healthcare was 11.50% per year.
During the past 3 years, the average Revenue Per Share Growth Rate was 1.20% per year.
During the past 5 years, the average Revenue Per Share Growth Rate was -13.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
The historical rank and industry rank for Oneview Healthcare's Revenue per Share or its related term are showing as below:
ASX:ONE'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -42.3 Med: -27.2 Max: 1.2
Current: 1.2
During the past 10 years, Oneview Healthcare's highest 3-Year average Revenue Per Share Growth Rate was 1.20% per year. The lowest was -42.30% per year. And the median was -27.20% per year.
ASX:ONE's 3-Year Revenue Growth Rate is ranked worse than 67.16% of 612
companies
in the Healthcare Providers & Services industry
Industry Median: 6.95
vs ASX:ONE: 1.20
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Oneview Healthcare Revenue per Share Related Terms
Oneview Healthcare Revenue per Share Historical Data
* Premium members only.
The historical data trend for Oneview Healthcare's Revenue per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:ONE vs VEEV, BTSG, TEM: Revenue per Share Comparison
For the Health Information Services subindustry, Oneview Healthcare's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Oneview Healthcare PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Oneview Healthcare's PS Ratio distribution charts can be found below:
* The bar in red indicates where Oneview Healthcare's PS Ratio falls into.
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Oneview Healthcare's Revenue Per Share for the fiscal year that ended in Dec. 2025 is calculated as
Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.03
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Oneview Healthcare (ASX:ONE) has a Revenue per Share of A$0.03 as of Jun. 2026. Revenue per share equals the per-share value of a company's sales. View historical data on Oneview Healthcare and its competitors. According to the industry distribution chart, Oneview Healthcare ranks #411 out of 612 companies in the Healthcare Providers & Services industry, placing it in the top 67.2%.
Is Oneview Healthcare's Revenue per Share too high?
Oneview Healthcare's current Revenue per Share is A$0.03. Based on the distribution chart, Oneview Healthcare ranks #411 out of 612 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Oneview Healthcare has a GF Score™ of 37/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Oneview Healthcare's Revenue per Share compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Oneview Healthcare ranks #411 out of 612 companies for Revenue per Share. This places Oneview Healthcare in the lower half of its industry. The industry median Revenue per Share is 6.95. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue per Share for a Healthcare Providers & Services company?
The median Revenue per Share among Healthcare Providers & Services companies is 6.95, based on 612 companies in the industry. Companies in the top quartile (top 25%) have a Revenue per Share significantly above this median, while those in the bottom quartile fall well below. However, Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue per Share mean?
A high Revenue per Share can signal that a stock is expensive relative to its fundamentals. Revenue per share equals the per-share value of a company's sales. View historical data on Oneview Healthcare and its competitors. For the Healthcare Providers & Services industry, the median Revenue per Share is 6.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oneview Healthcare's current Revenue per Share is A$0.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oneview Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Oneview Healthcare (ASX:ONE) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.39, compared to a current price of A$0.17 — trading 56.4% below its estimated fair value. The current Revenue per Share is A$0.03. Oneview Healthcare's overall GF Score™ is 37/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue per Share calculated?
Revenue per Share is calculated from a company's financial statements. For Oneview Healthcare (ASX:ONE), the current Revenue per Share is A$0.03 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Oneview Healthcare (ASX:ONE) Overvalued in 2026?
Based on GuruFocus' analysis, Oneview Healthcare stock appears to be undervalued.
The current stock price of A$0.17 is trading 56.4% below its estimated GF Value™ of A$0.39.
GuruFocus considers Oneview Healthcare to be Possible Value Trap.
Key valuation signals for ASX:ONE:
Revenue per Share: A$0.03
GF Value™: A$0.39 vs. price of A$0.17 (56.4% below fair value)
No single metric tells the full story. See the ASX:ONE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Oneview Healthcare PLC provides patient engagement and clinical workflow technology solutions to healthcare facilities. It serves hospitals and healthcare systems, academic medical centers, and pediatric hospitals. Oneview Healthcare's Care Experience Platform (CXP) provides a unified set of digital tools in a single bedside solution and connects patients, families, and care teams with services, education, and information during hospital stays. The company operates in one reportable segment, which provides a patient engagement solution for the healthcare sector.
37GF Score
Get the complete analysis for ASX:ONE
Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:ONE has been successfully added to your 
